Published in
Esmo Open, Esmo Open, 3(8), p. 101173, 2023
DOI: 10.1016/j.esmoop.2023.101173
Links
Tools
A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer
Journal article published in 2023 by
G. Galffy,
I. Lugowska,
E. V. Poddubskaya,
B. C. Cho 
,
M.-J. Ahn,
J.-Y. Han,
W.-C. Su,
R. J. Hauke,
S. H. Dyar,
D. H. Lee,
P. Serwatowski,
D. L. Estelles,
V. R. Holden,
Y. J. Kim,
V. Vladimirov
and other authors.
,
M.-J. Ahn,
J.-Y. Han,
W.-C. Su,
R. J. Hauke,
S. H. Dyar,
D. H. Lee,
P. Serwatowski,
D. L. Estelles,
V. R. Holden,
Y. J. Kim,
V. Vladimirov
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 